Report Library
All ReportsSchizophrenia and Bipolar Disorder KOL Interview - Germany
March 23, 2023
A key opinion leader (KOL) based in Germany provides insights into prescribing habits, key marketed brands, and late-phase pipeline therapies for schizophrenia and bipolar disorder, as well as newly approved therapies such as ROVI’s Okedi.
This interview was conducted on 31 January 2023.
If you are a KOL Insight Subscriber, please access the interview from our KOL Insight portal (Subscribers only).
Biomedtracker will be offering KOL Reports and Physician Pulse Surveys for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (858) 200-2357.
For our disclosures, please read the Biomedtracker Research Standards.
Indications Covered: |
Bipolar Disorder
Schizophrenia |
Additional Resources: